Department of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410006, China.
Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410006, China.
Chin Med J (Engl). 2018 Jan 20;131(2):151-155. doi: 10.4103/0366-6999.222331.
SH3TC2, PMP2, and BSCL2 genes are related to autosomal recessive (AR) Charcot-Marie-Tooth (CMT) disease type 1, autosomal dominant (AD)-CMT1, and AD-CMT2, respectively. Pathogenic variants in these three genes were not well documented in Chinese CMT patients. Therefore, this study aims to detect SH3TC2, PMP2, and BSCL2 pathogenic variants in a cohort of 315 unrelated Chinese CMT families.
A total of 315 probands from 315 unrelated Chinese CMT families were recruited from the Department of Neurology of Third Xiangya Hospital and Xiangya Hospital. We screened for SH3TC2 pathogenic variants in 84 AR or sporadic CMT probands, PMP2 pathogenic variants in 39 AD or sporadic CMT1 probands, and BSCL2 pathogenic variants in 50 AD or sporadic CMT2 probands, using polymerase chain reaction and Sanger sequencing. All these patients were out of 315 unrelated Chinese CMT families and genetically undiagnosed after exclusion of pathogenic variants of PMP22, MFN2, MPZ, GJB1, GDAP1, HSPB1, HSPB8, EGR2, NEFL, and RAB7. Candidate variants were analyzed based on the standards and guidelines of American College of Medical Genetics and Genomics (ACMG). Clinical features were reevaluated.
We identified three novel heterozygous variants such as p.L95V (c.283C>G), p.L1048P (c.3143T>C), and p.V1105M (c.3313G>A) of SH3TC2 gene and no pathogenic variants of PMP2 and BSCL2 genes. Although evaluation in silico and screening in the healthy control revealed that the three SH3TC2 variants were likely pathogenic, no second allele variants were discovered. According to the standards and guidelines of ACMG, the heterozygous SH3TC2 variants such as p.L95V, p.L1048P, and p.V1105M were considered to be of uncertain significance.
SH3TC2, PMP2, and BSCL2 pathogenic variants might be rare in Chinese CMT patients. Further studies to confirm our findings are needed.
SH3TC2、PMP2 和 BSCL2 基因分别与常染色体隐性(AR)型腓骨肌萎缩症(CMT)1 型、常染色体显性(AD)-CMT1 和 AD-CMT2 相关。这三个基因的致病性变异在中国人 CMT 患者中尚未得到很好的记录。因此,本研究旨在检测 315 个无关中国 CMT 家族中 SH3TC2、PMP2 和 BSCL2 的致病性变异。
从第三湘雅医院和湘雅医院神经内科共招募了 315 名无关中国 CMT 家系的先证者。我们对 84 名 AR 或散发性 CMT 先证者进行了 SH3TC2 致病性变异筛查,对 39 名 AD 或散发性 CMT1 先证者进行了 PMP2 致病性变异筛查,对 50 名 AD 或散发性 CMT2 先证者进行了 BSCL2 致病性变异筛查,使用聚合酶链反应和 Sanger 测序。所有这些患者均为 315 个无关中国 CMT 家系的患者,在排除 PMP22、MFN2、MPZ、GJB1、GDAP1、HSPB1、HSPB8、EGR2、NEFL 和 RAB7 的致病性变异后,遗传诊断仍未明确。候选变异根据美国医学遗传学与基因组学学院(ACMG)的标准和指南进行分析。重新评估临床特征。
我们发现了三个新的杂合变异,即 SH3TC2 基因的 p.L95V(c.283C>G)、p.L1048P(c.3143T>C)和 p.V1105M(c.3313G>A),以及 PMP2 和 BSCL2 基因无致病性变异。尽管体外评估和健康对照筛查显示这三种 SH3TC2 变异可能具有致病性,但未发现第二种等位基因变异。根据 ACMG 的标准和指南,杂合 SH3TC2 变异如 p.L95V、p.L1048P 和 p.V1105M 被认为意义不明。
SH3TC2、PMP2 和 BSCL2 的致病性变异在中国人 CMT 患者中可能较为罕见。需要进一步的研究来证实我们的发现。